These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 28653770)

  • 21. Acetylator phenotyping: the urinary caffeine metabolite ratio in slow acetylators correlates with a marker of systemic NAT1 activity.
    Cribb AE; Isbrucker R; Levatte T; Tsui B; Gillespie CT; Renton KW
    Pharmacogenetics; 1994 Jun; 4(3):166-70. PubMed ID: 7920698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The associations of polymorphism of N-acetyltransferase 2 gene is associated with antituberculosis drug-induced hepatotoxicity in tuberculosis patients].
    An HR; Wu XQ; Wang ZY; Liang Y; Zhang JX
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jan; 45(1):36-40. PubMed ID: 21418817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-acetyltransferase polymorphism in patients with Behçet's disease.
    Aynacioglu AS; Bozkurt A; Nacak M; Kortunay S; Tunc R; Dincel A; Kayaalp SO
    Eur J Clin Pharmacol; 2001 Nov; 57(9):659-62. PubMed ID: 11791896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-acetyltransferase 2 polymorphism in patients infected with human immunodeficiency virus.
    Kaufmann GR; Wenk M; Taeschner W; Peterli B; Gyr K; Meyer UA; Haefeli WE
    Clin Pharmacol Ther; 1996 Jul; 60(1):62-7. PubMed ID: 8689813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Segregation analyses of four urinary caffeine metabolite ratios implicated in the determination of human acetylation phenotypes.
    Vincent-Viry M; Pontes ZB; Gueguen R; Galteau MM; Siest G
    Genet Epidemiol; 1994; 11(2):115-29. PubMed ID: 8013893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-acetyltransferase 2 enzyme genotype-phenotype discordances in both HIV-negative and HIV-positive Nigerians.
    Kotila OA; Fawole OI; Olopade OI; Ayede AI; Falusi AG; Babalola CP
    Pharmacogenet Genomics; 2019 Jul; 29(5):106-113. PubMed ID: 30882558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of acetylation phenotype with genotype coding for N-acetyltransferase (NAT2) in children.
    Zielińska E; Bodalski J; Niewiarowski W; Bolanowski W; Matusiak I
    Pediatr Res; 1999 Mar; 45(3):403-8. PubMed ID: 10088662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-acetylation among HIV-positive patients and patients with AIDS: when is fast, fast and slow, slow?
    O'Neil WM; Gilfix BM; DiGirolamo A; Tsoukas CM; Wainer IW
    Clin Pharmacol Ther; 1997 Sep; 62(3):261-71. PubMed ID: 9333101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study on Genotyping Polymorphism and Sequencing of N-Acetyltransferase 2 (NAT2) among Al-Ahsa Population.
    Zahra MA; Kandeel M; Aldossary SA; Al-Taher A
    Biomed Res Int; 2020; 2020():8765347. PubMed ID: 32626768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between the N-acetylation genetic polymorphism and bronchial asthma.
    Nacak M; Aynacioglu AS; Filiz A; Cascorbi I; Erdal ME; Yilmaz N; Ekinci E; Roots I
    Br J Clin Pharmacol; 2002 Dec; 54(6):671-4. PubMed ID: 12492617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in β-naphthylamine metabolism and toxicity in Chinese hamster ovary cell lines transfected with human CYP1A2 and NAT2*4, NAT2*5B or NAT2*7B N-acetyltransferase 2 haplotypes.
    Habil MR; Salazar-González RA; Doll MA; Hein DW
    Arch Toxicol; 2022 Nov; 96(11):2999-3012. PubMed ID: 36040704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotyping of the polymorphic N-acetyltransferase (NAT2) and loss of heterozygosity in bladder cancer patients.
    Schnakenberg E; Ehlers C; Feyerabend W; Werdin R; Hübotter R; Dreikorn K; Schloot W
    Clin Genet; 1998 May; 53(5):396-402. PubMed ID: 9660060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arylamine N-acetyltransferase-2 genotypes in the Thai population.
    Kukongviriyapan V; Prawan A; Tassaneyakul W; Aiemsa-Ard J; Warasiha B
    Br J Clin Pharmacol; 2003 Mar; 55(3):278-81. PubMed ID: 12630978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-acetyltransferase-2 polymorphism, smoking and type 1 diabetic nephropathy.
    Korpinen E; Groop PH; Rautio A; Madácsy L; Reunanen A; Vaarala O; Akerblom HK
    Pharmacogenetics; 1999 Oct; 9(5):627-33. PubMed ID: 10591543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplification.
    Doll MA; Fretland AJ; Deitz AC; Hein DW
    Anal Biochem; 1995 Nov; 231(2):413-20. PubMed ID: 8594994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NAT2 and CYP1A2 phenotyping with caffeine: head-to-head comparison of AFMU vs. AAMU in the urine metabolite ratios.
    Nyéki A; Buclin T; Biollaz J; Decosterd LA
    Br J Clin Pharmacol; 2003 Jan; 55(1):62-7. PubMed ID: 12534641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ultra-slow NAT2*6A haplotype is associated with reduced higher cognitive functions in an elderly study group.
    Selinski S; Getzmann S; Gajewski PD; Blaszkewicz M; Hengstler JG; Falkenstein M; Golka K
    Arch Toxicol; 2015 Dec; 89(12):2291-303. PubMed ID: 26615528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians.
    Aklillu E; Carrillo JA; Makonnen E; Bertilsson L; Djordjevic N
    Eur J Clin Pharmacol; 2018 Jul; 74(7):903-911. PubMed ID: 29589062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetylation polymorphism expression in patients before and after liver transplantation: influence of host/graft genotypes.
    Bendriss EK; Bechtel YC; Paintaud G; Brientini MP; Mantion G; Miguet JP; Bennani A; Bechtel PR
    Pharmacogenetics; 1998 Jun; 8(3):201-9. PubMed ID: 9682266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk.
    Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A
    Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.